Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Thompson

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Journal of Surgical Oncology|February 10, 2019
Surgeon perception versus reality: Opioid use after breast cancer surgeryKo Un Park, Kristin Kyrish, John Terrell, et al.
Breast (Edinburgh, Scotland)|April 10, 2016
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane ProjectAnthony J Maxwell, Karen Clements, David J Dodwell, et al.
Breast Cancer Research : BCR|November 20, 2012
ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFRChristoforos Thomas, Gayani Rajapaksa, Fotis Nikolos, et al.
BMJ Open|March 14, 2019
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Breast Cancer Research : BCR|September 17, 2024
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)Elissa M Ozanne, Kellyn Maves, Angela C Tramontano, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Research Square|September 11, 2023
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Journal of Surgical Oncology|February 10, 2019
Surgeon perception versus reality: Opioid use after breast cancer surgeryKo Un Park, Kristin Kyrish, John Terrell, et al.
Breast (Edinburgh, Scotland)|April 10, 2016
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane ProjectAnthony J Maxwell, Karen Clements, David J Dodwell, et al.
Breast Cancer Research : BCR|November 20, 2012
ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFRChristoforos Thomas, Gayani Rajapaksa, Fotis Nikolos, et al.
BMJ Open|March 14, 2019
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.
Breast (Edinburgh, Scotland)|April 14, 2010
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialKelly-Anne Phillips, Karin Ribi, Zhuoxin Sun, et al.
Breast Cancer Research and Treatment|November 4, 2010
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialKelly-Anne Phillips, Julie Aldridge, Karin Ribi, et al.
Breast Cancer Research : BCR|September 17, 2024
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)Elissa M Ozanne, Kellyn Maves, Angela C Tramontano, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Research Square|September 11, 2023
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Pageof 10